{"id":"W2599211667","doi":"10.1200/jco.2013.31.15_suppl.7500","title":"START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Gastroenterology; Cancer; Stage (stratigraphy); Phases of clinical research; Population; Lung cancer; Placebo; Hazard ratio; Chemotherapy; Surgery; Oncology; Urology; Clinical trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001463832,0.001234683,0.001289411,0.0004577418,0.0003181108,0.0007317192,0.0009664647,0.00100696,0.005072011],"category_scores_gemma":[0.0004444066,0.0004738794,0.0009098172,0.0003165075,0.0007725239,0.0004820806,0.0004382979,0.00217545,0.001048063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007226869,"about_ca_system_score_gemma":0.00142663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009800592,"about_ca_topic_score_gemma":0.003796437,"domain_scores_codex":[0.9996973,0.0001428461,0.00001003205,0.00003623268,0.00004322429,0.00007037647],"domain_scores_gemma":[0.9995143,0.00007814675,0.00008695382,0.0000267549,0.00002460137,0.0002692395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6891614,0.08462262,0.009837876,0.001363498,0.001628155,0.0004737713,0.0002800315,0.002915675,0.09674352,0.0004582104,0.009908915,0.1026064],"study_design_scores_gemma":[0.5459466,0.4301882,0.01132851,0.00004986849,0.0004934006,0.0002198894,0.00004422504,0.0008895188,0.006517657,0.0001411485,0.004159177,0.00002182621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847209,0.003656635,0.00116679,0.0004019224,0.000154508,0.005310349,0.00199491,0.0002353327,0.002358621],"genre_scores_gemma":[0.9726515,0.00309535,0.003551378,0.001202142,0.0002217138,0.007636161,0.005699488,0.00005697564,0.005885232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005072011,"threshold_uncertainty_score":0.01696754,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07376836886841615,"score_gpt":0.4737267098095047,"score_spread":0.3999583409410885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}